CA2118709A1 - Essai par capture enzymatique - Google Patents

Essai par capture enzymatique

Info

Publication number
CA2118709A1
CA2118709A1 CA002118709A CA2118709A CA2118709A1 CA 2118709 A1 CA2118709 A1 CA 2118709A1 CA 002118709 A CA002118709 A CA 002118709A CA 2118709 A CA2118709 A CA 2118709A CA 2118709 A1 CA2118709 A1 CA 2118709A1
Authority
CA
Canada
Prior art keywords
sache
enzyme
ligand
human
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002118709A
Other languages
English (en)
Inventor
David M. Brennand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AVALON BIOSCIENCES Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2118709A1 publication Critical patent/CA2118709A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002118709A 1991-09-09 1992-09-09 Essai par capture enzymatique Abandoned CA2118709A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9119240.1 1991-09-09
GB919119240A GB9119240D0 (en) 1991-09-09 1991-09-09 Enzyme capture assay for human secretory acetyl cholinesterase
PCT/GB1992/001650 WO1993005398A1 (fr) 1991-09-09 1992-09-09 Essai de capture d'enzyme

Publications (1)

Publication Number Publication Date
CA2118709A1 true CA2118709A1 (fr) 1993-03-18

Family

ID=10701127

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002118709A Abandoned CA2118709A1 (fr) 1991-09-09 1992-09-09 Essai par capture enzymatique

Country Status (6)

Country Link
EP (1) EP0604509A1 (fr)
JP (1) JPH06510851A (fr)
AU (1) AU2566292A (fr)
CA (1) CA2118709A1 (fr)
GB (1) GB9119240D0 (fr)
WO (1) WO1993005398A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1734367A1 (fr) * 2005-06-14 2006-12-20 Cellzome Ag Procédé pour identifier des nouveaux composés qui interagissent avec une enzyme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59208462A (ja) * 1983-04-29 1984-11-26 バイオウィッテッカー・インコーポレーテッド キモパパインの分析法
IL75553A (en) * 1985-06-18 1993-07-08 Yeda Res & Dev Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto
EP0436654A1 (fr) * 1988-09-30 1991-07-17 The University Of Vermont And State Agricultural College Immunoanalyses pour la detection de proteases de serine presentant une activite catalytique
GB8927389D0 (en) * 1989-12-04 1990-01-31 Jehanli Ahmed M T Monoclonal antibodies

Also Published As

Publication number Publication date
WO1993005398A1 (fr) 1993-03-18
AU2566292A (en) 1993-04-05
EP0604509A1 (fr) 1994-07-06
JPH06510851A (ja) 1994-12-01
GB9119240D0 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
US7754436B2 (en) Diagnostic assay for stroke
EP0540591B1 (fr) Detection de necrose cellulaire au moyen d'analyses de detection de la spectrine et des produits de decomposition de cette derniere
US7462495B2 (en) Methods and compositions for use in diagnosing and characterizing chronic immune disease
US5976817A (en) Diagnostic method for detecting Alzheimer's disease in living patients
EP0856158B1 (fr) Dosage permettant de diagnostiquer la demence
US5834214A (en) Detection of pancreatitis-associated protein for screening for cystic fibrosis
US6080554A (en) Methods and compositions for use in characterizing multiple sclerosis disease activity in a subject
GB2218100A (en) Conjugates for the detection and/or quantification of antigenic substances in body fluids
CA2118709A1 (fr) Essai par capture enzymatique
US7166473B2 (en) Transferrin assay
US7713515B2 (en) Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis
JP4491572B2 (ja) 酵素免疫測定法による試料中の測定対象物質の測定試薬及び測定方法
US20080058429A1 (en) Diagnosis Of Primary Open Angle Glaucoma
JPH06160384A (ja) 糖尿病性腎症の早期診断法
KR20010074986A (ko) 췌장 기능 장애를 검출하기 위한 진단 방법
CA2218535A1 (fr) Expression de proteine modifiee dans des trophoblastes hypoxiques
JP2003277398A (ja) トランスフェリンを含む免疫複合体に対する抗体、抗体の製造方法、ハイブリドーマ及び免疫測定方法

Legal Events

Date Code Title Description
FZDE Discontinued